Effectiveness and Limitations of cancer immunotherapy: a narrative literature review.

Cancer immunotherapy is an important approach to cancer treatment that uses or modifies the body's immune system to recognize and attack cancer cells. Different forms of immunotherapy, including immune checkpoint inhibitors and adoptive cell therapy, have produced meaningful clinical benefits in selected patients. However, their effectiveness varies according to cancer type, tumor characteristics, and individual patient factors. This narrative literature review examines the basic mechanisms of cancer immunotherapy, evidence of its effectiveness, and its major limitations. Published literature indicates that some patients experience substantial and lasting responses, while others do not respond or develop resistance. Treatment-related adverse effects, high costs, and unequal access also present important challenges. Overall, immunotherapy represents a valuable development in oncology, but further research is needed to improve patient selection, treatment safety, and clinical outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-31
DOI
https://doi.org/10.5281/zenodo.23805558
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Effectiveness and Limitations of cancer immunotherapy: a narrative literature review.

Maryam shehzadi Ghulam Mustafa
Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
preprint

Effectiveness and Limitations of cancer immunotherapy: a narrative literature review.

Maryam shehzadi Ghulam Mustafa
preprint en

Abstract

Cancer immunotherapy is an important approach to cancer treatment that uses or modifies the body's immune system to recognize and attack cancer cells. Different forms of immunotherapy, including immune checkpoint inhibitors and adoptive cell therapy, have produced meaningful clinical benefits in selected patients. However, their effectiveness varies according to cancer type, tumor characteristics, and individual patient factors. This narrative literature review examines the basic mechanisms of cancer immunotherapy, evidence of its effectiveness, and its major limitations. Published literature indicates that some patients experience substantial and lasting responses, while others do not respond or develop resistance. Treatment-related adverse effects, high costs, and unequal access also present important challenges. Overall, immunotherapy represents a valuable development in oncology, but further research is needed to improve patient selection, treatment safety, and clinical outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon